Dopamine D1 receptor partial agonist

This page covers all Dopamine D1 receptor partial agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Dopamine D1 receptor (DRD1).

Targets

Dopamine D1 receptor (DRD1)

Phase 3 pipeline (1)

• DSP-5423P Active-to-Flex · Sumitomo Pharma Co., Ltd. · Neurology/Psychiatry
  DSP-5423P is a selective dopamine D1 receptor partial agonist designed to modulate dopaminergic signaling in the central nervous system.

Patent intelligence

• dopamine d1 receptor partial agonist patent landscape — aggregated cliff calendar, attackable patents, originator estates